Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome. (Q37222119)
Jump to navigation
Jump to search
scientific article published on 13 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome. |
scientific article published on 13 May 2009 |
Statements
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome (English)
Azra Raza
Naomi Galili
Leonel Ochoa
Lawrence Piro
Stephanie Williams
Howard Burris
Peter Curtin
James G Keck
Marsha Jones
Lisa Meng
Gail L Brown
Stefan Faderl
13 May 2009
1 reference
1 reference